Phospho-STAT-6 levels in nasal scrapings of asthmatic patients increases following nasal challenge with grass but not house dust mite allergen Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009
Importance of large particle in bronchial challenge test in mite allergic asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 588s Year: 2004
Usefulness of nasal provocation test in the diagnosis of mite allergic rhinitis: Standard or rapid? Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013
Correlation between nasal eosinophilic inflammation and bronchial reactivity to methacholine in allergic children sensitized to house dust mites (HDM) Source: Eur Respir J 2002; 20: Suppl. 38, 172s Year: 2002
OPURIT: O malizumab-p rotected u ltra r ush s pecific i mmunotherapy in severe asthmatic patients with house dust mite allergy Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011
The diagnostic value of nasal provocation tests in children with perennial allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 483s Year: 2006
Diagnostic utility of serum periostin for house dust mite sublingual immunotherapy response in allergic rhinitis Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials Year: 2021
Efficacy of specific allergy vaccination in house dust mite asthma Source: Eur Respir J 2005; 26: Suppl. 49, 465s Year: 2005
Sensitisation to house dust mite: its association with bronchial hyperresponsiveness and lung function in asthmatic children Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009
Clinical efficiency of sublingual and subcutaneous allergenspecific immunotherapy with household dust mite allergen in patients with persistent allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 438s Year: 2006
The association of adult bronchial responsiveness with IgE sensitisation and exposure to cat and house dust mite allergen Source: Eur Respir J 2006; 28: Suppl. 50, 145s Year: 2006
Allergen exposure in nondog and nonhouse dust mite sensitized atopic asthmatic subjects; effect on bronchial reactivity Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001
Sublingual immunotherapy is an established therapy for house dust mite sensitive allergic rhinitis and/or asthma Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007
Characterisation of asthma among adults with and without childhood farm contact Source: Eur Respir J 2007; 29: 1169-1173 Year: 2007
Safety of subcutaneous immunotherapy with standardized extracts of house dust mite in allergic asthmatic subjects Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002
Nasal mucosa response to specific challenge test in patients exposed to wood dust Source: Eur Respir J 2004; 24: Suppl. 48, 370s Year: 2004
House dust mite sublingual immunotherapy reduces type 2 biomarkers in allergic asthma Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020
Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021
Nasal provocation tests and bronchial hyperresponsivness in patients with perennial rhinitis Source: Eur Respir J 2002; 20: Suppl. 38, 218s Year: 2002
High doses of sublingual tablets of house dust mite allergen extracts: Lung function assessment in a phase I study in adults with mite-associated allergic asthma Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015